Original Scientific Paper EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(EUROASPIRE III) survey was to determine whether the Joint European Societies ’ guidelines on cardiovascular prevention are being followed in everyday clinical practice and to describe the lifestyle, risk factor and therapeutic management in patients with coronary heart disease (CHD) in Europe. Methods The EUROASPIRE III survey was carried out in 2006–2007 in 76 centres from selected geographical areas in 22 countries in Europe. Consecutive patients, with a clinical diagnosis of CHD, were identified retrospectively and then followed up, interviewed and examined at least 6 months after their coronary event. Results Thirteen thousand nine hundred and thirty-five medical records (27 % women) were reviewed and 8966 patient